Netris Pharma
PrivateLast Round
Grant
May 28, 2026
Total Funding Raised
$48.64M
Company Overview
Netris Pharma operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Grant round in May 2026.
Netris Pharma is a biotechnology company that develops anti-cancer therapeutic molecules designed to overcome resistance to oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Netris Pharma Comparables
Compare Netris Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medannex Ltd | 81% | |
| Compugen Ltd. | 78% | |
| Alethia Biotherapeutics | 77% |
For institutional investors. Book with your work email.
Netris Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2026 | ||||
| Series A Extension | Dec 19, 2023 | ||||
| Grant | Jan 19, 2023 | ||||
| Grant | Dec 16, 2021 | ||||
| Series A | Dec 23, 2020 |
For institutional investors. Book with your work email.
Netris Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Eclosion Ventures | Series A |
| Eurostars SME programme | Grant |
| Wille Finance AG | Series A |
| Horizon Europe | Grant |
| Bpifrance | Series A |
| EIC Fund | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 33% MoM.
- Oct 19, 2025
Results for drug candidate NP137 to be presented at ESMO Congress 2025.
For institutional investors. Book with your work email.
Netris Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Netris Pharma's valuation, stock price, and market status.
Is Netris Pharma a public or private company?
Netris Pharma is a private company.
What is the current stock price of Netris Pharma?
Netris Pharma is a private company, so its shares have no public market price. Caplight tracks Netris Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Netris Pharma worth (valuation)?
Valuation information for Netris Pharma is not publicly available.
Can I buy Netris Pharma stock?
Netris Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Netris Pharma's last funding round?
Netris Pharma's most recent funding round was Grant on May 28, 2026.
Who are the main investors in Netris Pharma?
Key investors in Netris Pharma include EIC Fund.
Will Netris Pharma IPO soon?
No public IPO plans have been announced for Netris Pharma.
How can I track Netris Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Netris Pharma's shares on secondary markets.